[PubMed: 8941209] Pabst R, Gehrke I
Hookah sellers had protested outside City Hall for such an exemption, arguing it was needed to protect a tradition cherished by Arabs, Armenians and other communities in Los Angeles
Of this, the state allocated $500,000 in state funds to tobacco prevention in fiscal year 2018, just 0.5 percent of the Centers for Disease Control and Preventions annual spending target
Our biomarker methods Assessment of the Exposure to Tobacco-Specific Nitrosamines and Minor Tobacco Alkaloids in Users of Various Tobacco/Nicotine Products Scherer G, Scherer M, Mtze J, Hauke T, Pluym N Chemical Research in Toxicology, doi: 10.1021/acs.chemrestox.2c00020 Wastewater-Based Epidemiology (WBE): Potential Application for Assessing the Use of Conventional and New Generation Tobacco and Nicotine Products Gerhard Scherer, Nikola Pluym, Max Scherer Contributions to Tobacco & Nicotine Research Assessing the exposure to smoke from electronic cigarettes by biomarkers Scherer G, Hagedorn H-W, Riedel K, Scherer M CORESTA SSPT 2013, Seville, Spain Biomarkers of Exposure Specific to E-vapor Products Based on Stable-Isotope Labeled Ingredients Landmesser A, Scherer M, Pluym N, Sarkar M, Edmiston J, Niessner R, Scherer G Nicotine & Tobacco Research, Volume 21, doi: 10.1093/ntr/nty204 Biomarkers of exposure specific to e-vapor products based on stable-isotope labeled ingredients Landmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N SRNT 2018, Baltimore, USA Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredients methods Landmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbhel, Austria Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredientsresults Landmesser A, Scherer M, Scherer G, Sarkar M, Edmiston J, Pluym N CORESTA SSPT 2017, Kitzbhel, Austria Biomarkers of exposure specific to e-vapor products based on stable-isotope labelled ingredientsstudy design Landmesser A, Pluym N, Scherer G, Sarkar M, Edmiston J, Scherer M CORESTA SSPT 2017, Kitzbhel, Austria Collaborative Method Performance Study of the Measurement of Nicotine, Its Metabolites, and Total Nicotine Equivalents in Human Urine Wang L, Bernert JT, Benowitz NL, Feng J, Jacob P 3rd, McGahee E, Caudill SP, Scherer G, Scherer M, Pluym N, Doig MV, Newland K, Murphy SE, Caron NJ, Sander LC, Shimizu M, Yamazaki H, Kim S, Langman LJ, Pritchett JS, Sniegoski LT, Li Y, Blount BC, Pirkle JL Cancer Epidemiology, Biomarkers & Prevention, Volume 27, doi: 10.1158/1055-9965 Saliva as a matrix for human biomonitoring in occupational and environmental medicine Michalke B, Rossbach B, Gen T, Schferhenrich A, Scherer G International Archives of Occupational and Environmental Health, volume 88, doi: 10.1007/s00420-014-0938-5 Simple, fast and sensitive LC-MS/MS analysis for the simultaneous quantification of nicotine and 10 of its major metabolites Piller M, Gilch G, Scherer G, Scherer M Journal of Chromatography B, Volumes 951952, doi: 10.1016/j.jchromb.2014.01.025 Ultra-sensitive method for the determination of nicotine in PK studies with next generation products Wanderer F, Pluym N, Scherer G, Scherer M CORESTA Congress 2016, Berlin, Germany Assessment of nicotine delivery and uptake in users of various tobacco / nicotine products Scherer G, Mtze J, Pluym N, Scherer M Current Research in Toxicology, Volume 3, 100067 A simple and robust UPLC-SRM/MS method to quantify urinary eicosanoids Sterz K, Scherer G, Ecker J Journal of Lipid Research, Volume 53, doi: 10.1194/jlr.D023739 Analysis of Urinary Eicosanoids by LC-MS/MS Reveals Alterations in the Metabolic Profile after Smoking Cessation Goettel M, Niessner R, Scherer M, Scherer G, Pluym N Chemical Research in Toxicology, Volume 31, doi: 10.1021/acs.chemrestox Identifying suitable biomarkers of biological effects (BOBEs) for evaluating reduced risk products Scherer G, Pluym N, Scherer M CORESTA Congress 2018, Biomarker Workshop, Kunming, China Metabolomic Fingerprinting in Various Body Fluids of a Diet-Controlled Clinical Smoking Cessation Study Using a Validated GC-TOF-MS Metabolomics Platform Goettel M, Niessner R, Mueller D, Scherer M, Scherer G, Pluym N Journal of Proteome Research, Volume 16(10), doi: 10.1021/acs.jproteome.7b00128
and eReferral to utilize electronic health record (EHR) technology
